Numerai’s Cardiovascular Systems, Inc. CSII Stock Holding History

Numerai’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-27,254	Closed	-$371K	–	211
2022 Q4	$371K	Buy	+27,254	New	+$379K	0.25%	94

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Numerai's CSII Position: Q1 2023 in Review

Numerai sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 27,254 shares — an estimated $371K sold.

Numerai first reported a position in CSII in Q4 2022 and held it in 1 quarter. The position peaked at $371K in Q4 2022. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Numerai reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Numerai sold 27,254 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $371K.
Numerai first reported a position in Cardiovascular Systems, Inc. in Q4 2022 and held it in 1 quarter.
Numerai's Cardiovascular Systems, Inc. position peaked at $371K in Q4 2022.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Numerai's 13F filing for Q1 2023, filed 12 May 2023.